Skarpa assists clients in sales and acquisitions of companies valued between 20 and 300 million SEK.
has been acquired by
Fairness Opinion to the Board of Directors for the public offer from Bygghemma
Valuation of options premium
Skarpa has assisted the sellers
Fairness Opinion of Karessa Pharma in fusion with Klaria Pharma
